15-Epi-lipoxin A4 inhibits the progression of endometriosis in a murine model

article OA: bronze CC0 ⤵ 15 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-08

15-Epi-lipoxin A4 significantly reduced endometriotic lesion size and vascularization in a mouse model, indicating a potential therapeutic role in inhibiting endometriosis progression.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Anti-Inflammatory Agents, Non-Steroidal Endometriosis Endometrium Lipoxins Animals Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Non-Steroidal Ascitic Fluid Ascitic Fluid Ascitic Fluid Disease Models, Animal Disease Progression Down-Regulation Endometriosis Endometriosis Endometriosis Endometrium Endometrium Endometrium Endometrium

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (38)

Cited by (15)

Source provenance

europepmc
last seen: 2026-06-21T06:12:49.409960+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:14:11.755070+00:00
License: CC0 · commercial use OK